Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management

[1]  Y. Probst,et al.  Short-term effects of fish and fish oil consumption on total and high molecular weight adiponectin levels in overweight and obese adults. , 2013, Metabolism: clinical and experimental.

[2]  M. Krebs,et al.  Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. , 2012, The American journal of clinical nutrition.

[3]  E. Ntzani,et al.  Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. , 2012, JAMA.

[4]  M. Quon,et al.  Significant differential effects of omega-3 fatty acids and fenofibrate in patients with hypertriglyceridemia. , 2012, Atherosclerosis.

[5]  K. Morino,et al.  Effects of a fish-based diet on the serum adiponectin concentration in young, non-obese, healthy Japanese subjects. , 2010, Journal of atherosclerosis and thrombosis.

[6]  S. Evans,et al.  Dietary n-3:n-6 fatty acid ratios differentially influence hormonal signature in a rodent model of metabolic syndrome relative to healthy controls , 2010, Nutrition & metabolism.

[7]  G. Siest,et al.  Expression of inflammatory molecules and associations with BMI in children , 2010, European journal of clinical investigation.

[8]  K. Sworczak,et al.  Adipose tissue activity in relation to overweight or obesity. , 2010, Endokrynologia Polska.

[9]  S. Devkota,et al.  A high protein moderate carbohydrate diet fed at discrete meals reduces early progression of N-methyl-N-nitrosourea-induced breast tumorigenesis in rats , 2010, Nutrition & metabolism.

[10]  M. Garg,et al.  Plasma n-3 Polyunsaturated Fatty Acids are negatively associated with obesity. , 2009, The British journal of nutrition.

[11]  Barbara Bloom,et al.  Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. , 2009, National health statistics reports.

[12]  A. Geelen,et al.  No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: a randomized controlled trial in healthy, middle-aged individuals , 2009, European Journal of Clinical Nutrition.

[13]  D. Hougaard,et al.  Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects. , 2009, Metabolism: clinical and experimental.

[14]  P. Reiss,et al.  Zidovudine/Lamivudine for HIV-1 Infection Contributes to Limb Fat Loss , 2009, PloS one.

[15]  Å. Vårtun,et al.  Coronary heart disease, serum lipids, platelets and dietary fish in two communities in northern Norway. , 2009, Acta medica Scandinavica.

[16]  S. Nomura,et al.  Effects of eicosapentaenoic acid on endothelial cell-derived microparticles, angiopoietins and adiponectin in patients with type 2 diabetes. , 2009, Journal of atherosclerosis and thrombosis.

[17]  D. Mozaffarian,et al.  The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. , 2008, Clinical chemistry.

[18]  T. Funahashi,et al.  Prognostic value of adiponectin for cardiovascular disease and mortality. , 2008, The Journal of clinical endocrinology and metabolism.

[19]  B. Person,et al.  Nutritional Deficiencies in Morbidly Obese Patients: A New Form of Malnutrition? , 2008, Obesity surgery.

[20]  W. Harris,et al.  Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. , 2008, Atherosclerosis.

[21]  A. Farmer,et al.  Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. , 2008, The Cochrane database of systematic reviews.

[22]  O. Receveur,et al.  Could the Quality of Dietary Fat, and Not Just Its Quantity, Be Related to Risk of Obesity? , 2008, Obesity.

[23]  Min-Seon Kim,et al.  Essential Role of Mitochondrial Function in Adiponectin Synthesis in Adipocytes , 2007, Diabetes.

[24]  Y. Kamei,et al.  Increased Adiponectin Secretion by Highly Purified Eicosapentaenoic Acid in Rodent Models of Obesity and Human Obese Subjects , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[25]  J. Tune,et al.  Adipokines and Coronary Vasomotor Dysfunction , 2007, Experimental biology and medicine.

[26]  J. Schölmerich,et al.  High‐fat Diets: Modeling the Metabolic Disorders of Human Obesity in Rodents , 2007, Obesity.

[27]  C. Herder,et al.  Relationship between adipocyte size and adipokine expression and secretion. , 2007, The Journal of clinical endocrinology and metabolism.

[28]  A. Martí,et al.  Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: role of apoptosis, adiponectin and tumour necrosis factor-α , 2007, British Journal of Nutrition.

[29]  G. Lip,et al.  Effects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarction. , 2007, International journal of cardiology.

[30]  Dariush Mozaffarian,et al.  Fish intake, contaminants, and human health: evaluating the risks and the benefits. , 2006, JAMA.

[31]  Vineet Chopra,et al.  Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. , 2006, European heart journal.

[32]  J. Danesh,et al.  Adiponectin and Coronary Heart Disease: A Prospective Study and Meta-Analysis , 2006, Circulation.

[33]  Kohjiro Ueki,et al.  Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. , 2006, The Journal of clinical investigation.

[34]  E. Ravussin,et al.  Role of adiponectin in human skeletal muscle bioenergetics. , 2006, Cell metabolism.

[35]  A. Bartke,et al.  Adipocytokines and lipid levels in Ames dwarf and calorie-restricted mice. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[36]  M. Gillum,et al.  Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice. , 2006, Diabetes.

[37]  Young-sil Yoon,et al.  Mitochondria are impaired in the adipocytes of type 2 diabetic mice , 2006, Diabetologia.

[38]  M. Hosseinzadeh‐Attar,et al.  Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet , 2006, Diabetologia.

[39]  S. Heymsfield,et al.  Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. , 2005, The Journal of clinical investigation.

[40]  G. Slama,et al.  Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[41]  Ildikó Kriszbacher,et al.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, New England Journal of Medicine.

[42]  J. Karbowska,et al.  Effect of DHEA on endocrine functions of adipose tissue, the involvement of PPAR gamma. , 2005, Biochemical pharmacology.

[43]  A. Martí,et al.  Eicosapentaenoic fatty acid increases leptin secretion from primary cultured rat adipocytes: role of glucose metabolism. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[44]  Adam Drewnowski,et al.  Changing the energy density of the diet as a strategy for weight management. , 2005, Journal of the American Dietetic Association.

[45]  J. Shaw,et al.  Effect of fish diets and weight loss on serum leptin concentration in overweight, treated-hypertensive subjects , 2004, Journal of hypertension.

[46]  A. Gressner,et al.  Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. , 2004, Clinical chemistry.

[47]  Nader Rifai,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[48]  V. Somers,et al.  Independent Association Between Plasma Leptin and C-Reactive Protein in Healthy Humans , 2004, Circulation.

[49]  Y. Shimada,et al.  Implications of plasma concentrations of adiponectin in patients with coronary artery disease , 2004, Heart.

[50]  C. Serhan,et al.  Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. , 2004, Prostaglandins & other lipid mediators.

[51]  Yi-Hao Yu,et al.  Chronological changes in metabolism and functions of cultured adipocytes: a hypothesis for cell aging in mature adipocytes. , 2004, American journal of physiology. Endocrinology and metabolism.

[52]  Philippe Froguel,et al.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.

[53]  N. Espat,et al.  Inhibition of activator protein-1 transcription factor activation by omega-3 fatty acid modulation of mitogen-activated protein kinase signaling kinases. , 2003, JPEN. Journal of parenteral and enteral nutrition.

[54]  M. Buemi,et al.  Leptin-dependent platelet aggregation in healthy, overweight and obese subjects , 2003, International Journal of Obesity.

[55]  J. Shaw,et al.  Overweight and obesity in Australia: the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab) , 2003, The Medical journal of Australia.

[56]  Alessandro Pontillo,et al.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. , 2003, JAMA.

[57]  C. Mantzoros,et al.  Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. , 2003, The Journal of clinical endocrinology and metabolism.

[58]  C. Mantzoros,et al.  Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy. , 2003, The Journal of clinical endocrinology and metabolism.

[59]  A. Simopoulos.  Omega-3 Fatty Acids in Inflammation and Autoimmune Diseases , 2002, Journal of the American College of Nutrition.

[60]  H. Lodish,et al.  Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl–CoA carboxylase inhibition and AMP-activated protein kinase activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[61]  K. Borch-Johnsen,et al.  Diabetes and impaired glucose tolerance among the inuit population of Greenland. , 2002, Diabetes care.

[62]  G. Slama,et al.  Dietary (n-3) polyunsaturated fatty acids up-regulate plasma leptin in insulin-resistant rats. , 2002, The Journal of nutrition.

[63]  V. Somers,et al.  Fish-Rich Diet, Leptin, and Body Mass , 2002, Circulation.

[64]  M. Matsuda,et al.  Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.

[65]  E. Jéquier.  Leptin Signaling, Adiposity, and Energy Balance , 2002, Annals of the New York Academy of Sciences.

[66]  D. Loskutoff,et al.  The Prothrombotic Effects of Leptin , 2001 .

[67]  Y. Terauchi,et al.  The Mechanisms by Which Both Heterozygous Peroxisome Proliferator-activated Receptor γ (PPARγ) Deficiency and PPARγ Agonist Improve Insulin Resistance* , 2001, The Journal of Biological Chemistry.

[68]  M. Matsuda,et al.  PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. , 2001, Diabetes.

[69]  L S Geiss,et al.  Prevalence of diabetes among Native Americans and Alaska Natives, 1990-1997: an increasing burden. , 2000, Diabetes care.

[70]  J W Erdman,et al.  AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. , 2000, Stroke.

[71]  F. Valagussa,et al.  The results of the GISSI-Prevenzione trial in the general framework of secondary prevention. , 2000, European heart journal.

[72]  K. Iida,et al.  Stimulation by eicosapentaenoic acids of leptin mRNA expression and its secretion in mouse 3T3-L1 adipocytes in vitro. , 2000, Biochemical and biophysical research communications.

[73]  G. Watts,et al.  Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. , 1999, The American journal of clinical nutrition.

[74]  A. Simopoulos,et al.  Essential fatty acids in health and chronic disease. , 1999, The American journal of clinical nutrition.

[75]  C. Boozer,et al.  The leptin-fat ratio is constant, and leptin may be part of two feedback mechanisms for maintaining the body fat set point in non-obese male Fischer 344 rats. , 1999, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[76]  S. Helton,et al.  Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity. , 1999, The Journal of surgical research.

[77]  S. Coppack,et al.  C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[78]  A. Ruello,et al.  Relationship between plasma leptin levels and the tumor necrosis factor-α system in obese subjects , 1999, International Journal of Obesity.

[79]  J. M. Beals,et al.  Human obesity protein, leptin , 1998 .

[80]  J. Halaas,et al.  Leptin and the regulation of body weight in mammals , 1998, Nature.

[81]  C. Drevon,et al.  Under- and overreporting of energy intake related to weight status and lifestyle in a nationwide sample. , 1998, The American journal of clinical nutrition.

[82]  K. Houseknecht,et al.  The biology of leptin: a review. , 1998, Journal of animal science.

[83]  T. Kirchgessner,et al.  Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. , 1997, The Journal of clinical investigation.

[84]  J. Peters,et al.  Polyunsaturated Fatty Acid Suppression of Hepatic Fatty Acid Synthase and S14 Gene Expression Does Not Require Peroxisome Proliferator-activated Receptor α* , 1997, The Journal of Biological Chemistry.

[85]  J. Flier,et al.  Leptin Prevents Fasting-Induced Suppression of Prothyrotropin-Releasing Hormone Messenger Ribonucleic Acid in Neurons of the Hypothalamic Paraventricular Nucleus. , 1997, Endocrinology.

[86]  J. M. Beals,et al.  Crystal structure of the obese protein Ieptin-E100 , 1997, Nature.

[87]  W. Harris,et al.  n-3 fatty acids and serum lipoproteins: animal studies. , 1997, The American journal of clinical nutrition.

[88]  Keiji Wakabayashi,et al.  Suppression of nitric oxide production in lipopolysaccharide-stimulated macrophage cells by omega 3 polyunsaturated fatty acids. , 1997, Japanese journal of cancer research : Gann.

[89]  R. Steiner,et al.  Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. , 1997, The Journal of clinical endocrinology and metabolism.

[90]  R. Miller,et al.  Transcription of the murine iNOS gene is inhibited by docosahexaenoic acid, a major constituent of fetal and neonatal sera as well as fish oils , 1996, The Journal of experimental medicine.

[91]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[92]  S. Endres,et al.  n-3 polyunsaturated fatty acids and human cytokine synthesis. , 1996, Current opinion in lipidology.

[93]  B. Lowell,et al.  Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action , 1995, Nature Medicine.

[94]  J. Stengård,et al.  Dietary Factors Determining Diabetes and Impaired Glucose Tolerance: A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study , 1995, Diabetes Care.

[95]  R. Simsolo,et al.  The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.

[96]  B. Spiegelman,et al.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.

[97]  A. Adler,et al.  Lower Prevalence of Impaired Glucose Tolerance and Diabetes Associated With Daily Seal Oil or Salmon Consumption among Alaska Natives , 1994, Diabetes Care.

[98]  Thl.  DOES FISH OIL LOWER BLOOD PRESSURE , 1993 .

[99]  P. Whelton,et al.  Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. , 1993, Archives of internal medicine.

[100]  Y. Nikitin,et al.  Prevalence of diagnosed diabetes in circumpolar indigenous populations. , 1992, International journal of epidemiology.

[101]  B. Goldin,et al.  Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. , 1991, The Journal of nutrition.

[102]  R. DiGiacomo,et al.  Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. , 1990, Arthritis and rheumatism.

[103]  P. Weber,et al.  The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. , 1989, The New England journal of medicine.

[104]  R L Weinsier,et al.  The effects of high and low energy density diets on satiety, energy intake, and eating time of obese and nonobese subjects. , 1983, The American journal of clinical nutrition.

[105]  E. Scott,et al.  Diabetes mellitus in Eskimos after a decade. , 1973, JAMA.

[106]  M. Danhof.  hiGhly Active AntiretrovirAl therApy in children , 2013 .

[107]  E. Schmidt,et al.  Low-dose fish oil supplementation increases serum adiponectin without affecting inflammatory markers in overweight subjects. , 2012, Nutrition research.

[108]  M. Wolters,et al.  Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk. , 2009, Atherosclerosis.

[109]  C. Ruxton,et al.  The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. , 2007, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[110]  J. Ren.  Leptin and hyperleptinemia – from friend to foe for cardiovascular function , 2004 .

[111]  E. Schmidt.  Marine n-3 fatty acids and thrombosis. , 2003, Thrombosis research.

[112]  M. Matoulek,et al.  Serum ghrelin levels in obese patients: the relationship to serum leptin levels and soluble leptin receptors levels. , 2003, Physiological research.

[113]  Y. Terauchi,et al.  The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. , 2001, The Journal of biological chemistry.

[114]  W. Buurman,et al.  Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals , 2001, International Journal of Obesity.

[115]  D. Loskutoff,et al.  The prothrombotic effects of leptin possible implications for the risk of cardiovascular disease in obesity. , 2001, Annals of the New York Academy of Sciences.

[116]  A. Barnett,et al.  Tumour necrosis factor-alpha exerts dual effects on human adipose leptin synthesis and release. , 2000, Molecular and cellular endocrinology.

[117]  J. Flier,et al.  Distinct Physiologic and Neuronal Responses to Decreased Leptin and Mild Hyperleptinemia , 1999 .

[118]  M. Lane,et al.  Leptin regulates proinflammatory immune responses. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[119]  W. Harris,et al.  n-3 fatty acids and serum lipoproteins: human studies. , 1997, The American journal of clinical nutrition.

[120]  F. Thibault,et al.  Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. , 1997, Advances in experimental medicine and biology.

[121]  J. Flier,et al.  Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. , 1997, Endocrinology.

[122]  E. Jéquier.  [Obesity. Impairment of energy intake or of energy expenditure]. , 1995, Annales d'endocrinologie.

[123]  B. Holub.  Omega-3 fatty acids in cardiovascular care , 2022 .